DelveInsight's Hypothalamic Obesity Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES, January 16, 2025 /EINPresswire ...

Rhythm Pharmaceuticals (NASDAQ:RYTM) reported its third-quarter 2024 earnings, highlighting a steady increase in revenue and strategic developments in product innovation and market expansion. Despite ...

The following is a summary of “Treatment of Hypothalamic Obesity With GLP-1 Analogs,” published in the November 2024 issue of Endocrinology by Dimitri and Roth. Damage to hypothalamic nuclei or ...

Hypothalamic Obesity Market Insights DelveInsight’s Hypothalamic Obesity Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES,.

Multiple neuropeptides have been identified that appear to modulate pathways within the hypothalamus to control appetite. Identifying potential therapeutic targets for the treatment of obesity ...

More recently, it has become evident that microglia, the resident macrophages of the CNS that drive neuroinflammation, may also be activated in obesity and can be relevant for regulation of ...

Mutations in a gene called OTP cause obesity by controlling the output ... and a Principal Investigator in the Center for Hypothalamic Research at UT Southwestern. Dr. Liu is also an Investigator ...

This discovery, published in Science Translational Medicine, could pave the way for more effective treatments for certain types of obesity ... Found in the hypothalamus—the part of the brain ...

“Our Phase 3 trial in acquired hypothalamic obesity (HO) remains on track, and we completed enrollment in the supplemental 12-patient Japanese cohort which will form the basis for a Japanese ...

New recommendations on how to define obesity would reduce the emphasis on body mass index and take into account health ...